Results 1 to 10 of about 30,811 (155)

Effects of a Personalized Nurse-Led Educational Program for New Patients Receiving Oral Anticoagulant Therapy after Mechanical Heart Valve Prosthesis Implantation on Adherence to Treatment

Journal of Chest Surgery, 2021
Background: Life-long anticoagulant therapy is mandatory for patients who undergo heart valve replacement with implantation of a mechanical prosthesis.
Rokeia Eltheni, Nikolaos Schizas, Nektaria Michopanou, Georgios Fildissis   +3 more
doaj   +8 more sources

Transcatheter tricuspid valve‐in‐valve implantation for degenerative surgical bio‐prosthesis using SAPIEN 3: A case series

Clinical Case Reports, 2021
We evaluated early outcomes of transcatheter valve‐in‐valve (ViV) implantation in patients with degenerated bio‐prosthesis in tricuspid position. Total of 5 patients were included in our case series.
Mann Chandavimol, Tawai Ngernsritrakul, Krissada Meemook, Sirin Apinyasawat, Tarinee Tangcharoen, Pavit Pienvichit, Piya Samankatiwat, Sarana Boonbaichaiyapruck   +7 more
doaj   +2 more sources

Transcatheter aortic valve‐in‐valve implantation of a corevalve in a degenerated stenotic sapien heart valve prosthesis

Catheterization and Cardiovascular Interventions, 2013
Treatment options for re‐stenotic aortic valve prosthesis implanted by transcatheter technique have not been evaluated systematically. We describe the case of a 75‐year‐old dialysis patient who was treated by transcatheter aortic valve implantation 3.5 years ago and now presented with severe stenosis of the percutaneous heart valve.
Rainer Hoffmann, Helge Möllmann, Shahram Lotfi   +2 more
openaire   +4 more sources

Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis

Journal of the American College of Cardiology, 2004
This study was done to assess the results of percutaneous heart valve (PHV) implantation in non-surgical patients with end-stage calcific aortic stenosis.Replacement of PHV has been shown to be feasible in animals and humans. We developed a PHV composed of three pericardial leaflets inserted within a balloon-expandable stainless steel stent.
Fabrice Bauer, Danielle Nusimovici, Martin B. Leon, Alain Cribier, Carla Agatiello, Laurent Sebagh, Jean-Paul Bessou, Hélène Eltchaninoff, Christophe Tron, Pierre-Yves Litzler, Assaf Bash   +10 more
openaire   +4 more sources

The structural-geometric and functional parameters of the heart in patients after mitral prosthetics with new full-flow valves in the long-term period [PDF]

КардиоСоматика, 2022
Aim. To compare the results of mitral valve replacement with the full-flow mechanical valve MedInzh-ST and the classical prosthesis MedInzh-2, to learn the structural and functional parameters of the heart depending from the prosthesis in the long-tern ...
Veronika S. Perekopskaya, Nataliya A. Morova, Valeriy N. Tsekhanovich   +2 more
doaj   +1 more source

The First Experience of Aortic Valve Repeated Replacement Using the “Valve in Valve” Technique in a Patient With Dysfunction of a Biological Prosthesis

Неотложная медицинская помощь, 2021
Introduction. Aortic valve replacement in cardiopulmonary bypass with suture fixation of the prosthesis is the “gold standard” in cardiac surgery. Currently, the frequency of use of heart valve bioprostheses is increasing in older patients.
V. V. Vladimirov, L. S. Kokov, A. I. Kovalyov, S. S. Niyazov, M. V. Parkhomenko, A. V. Redkoborody, N. V. Rubtsov, N. M. Bikbova, R. Sh. Muslimov   +8 more
doaj   +1 more source

First experience of transcatheter implantation of a Russian-made MedLab-CT prosthesis in a patient with dysfunction of biological mitral valve prosthesis

Российский кардиологический журнал, 2020
We present a case report of successful transcatheter implantation of a Russian-made cardiac valve prosthesis in a patient with dysfunction of biological mitral valve prosthesis (valve-in-valve).
A. V. Bogachev-Prokofiev, R. M. Sharifulin, M. A. Ovcharov, A. N. Pivkin, O. V. Krestyaninov, T. V. Antropova, M. A. Ovchinnikova, D. A. Astapov, A. V. Sapegin, A. V. Afanasyev, S. A. Budagaev, S. I. Zheleznev   +11 more
doaj   +1 more source

Balloon expandable vs. self-expandable transcatheter aortic valve prosthesis short-term results of retrospective study [PDF]

Българска кардиология, 2022
Transcutaneous aortic valve implantation has been established as an effective method for the treatment of highgrade aortic stenosis in non-operative, high-risk for conventional surgery patients.
Hr. Angelov, P. Simeonov, P. Krastev, F. Abedinov, J. Jorgova, D. Trendafilova   +5 more
doaj   +3 more sources

Cusp-overlap view reduces conduction disturbances and permanent pacemaker implantation after transcatheter aortic valve replacement even with balloon-expandable and mechanically-expandable heart valves

Frontiers in Cardiovascular Medicine, 2023
Background Conduction disturbances demanding permanent pacemaker implantation (PPI) remain a common complication after transcatheter aortic valve replacement (TAVR).
T. Stephan, Marvin Krohn-Grimberghe, Annika von Lindeiner genannt von Wildau, Christoph Buck, M. Baumhardt, Johannes Mörike, Birgid Gonska, Wolfgang Rottbauer, D. Buckert   +8 more
semanticscholar   +1 more source

Allegra Transcatheter Heart Valve inside a Degenerated Sutureless Aortic Bioprosthesis

The Thoracic & Cardiovascular Surgeon Reports, 2021
Transcatheter aortic valve-in-valve implantation (VIV) is increasingly being used to successfully treat degenerated surgical aortic valve bioprostheses (SAVs).
Maximilian Vondran, Bernd Abt, Holger Nef, Ardawan J. Rastan   +3 more
doaj   +1 more source